CHROMOLOGIC LLC — Department of Defense SBIR Phase II: DHA211-009
CHROMOLOGIC LLC — SBIR Phase II award from Department of Defense.
Phase II SBIR prototype / development signal
- Phase II is where Department of Defense funds deeper R&D after feasibility. Incumbents with Phase II history are serious competitors on adjacent topics.
- Use this award as past-performance context and to map customer organizations for STRATFI/TACFI-style transition planning.
- Obligated amount $1,099,933 is consistent with substantial Phase II-scale effort; compare to related awards from the same agency.
- Topic code DHA211-009 links this award to a solicitation family — search the same topic stem for incumbents and recompete timing.
- Amount
- $1,099,933
- Agency
- Department of Defense · Defense Health Program
- Program / Phase
- SBIR · Phase II
- Topic
- DHA211-009
- Solicitation
- 21.1
- NAICS
- —
- Place of performance
- CA
- Period
- 2022-09-01 → 2025-01-05
Description
In order to address this urgent need, ChromoLogic LLC (CL) proposes to develop a ceramic membrane based portable oxygen generator (CEMPOG) to support the supply of medical grade oxygen for forward surgical teams. Unlike the regular membrane separation process, CEMPOG adopts mixed ionic–electronic conducting (MIEC) ceramic membrane to generate ultrapure O2 from ambient air, in which the oxygen molecules absorbed on the membrane surface are catalytically disassociated in oxygen ions and the ions diffuse through the oxygen vacancies of perovskite oxides under a pressure gradient followed by recombination of ions and desorption of oxygen molecules on the permeate. The CEMPOG Phase I prototype exhibited capability to provide 95.6% O2 with ambient air as the only feedstock. Electric current is assigned to direct heat membrane surface up to 900 ºC to initialize and maintain the reaction. To control the energy consumption for pre-heating input air and entire HFM reactor, heat exchangers are applied to cool the product temperature down to 35 ºC.